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cause	is	yet	 to	be	 identified	 (Lesser,	Maron
&	Sharkey,	2011).		
-Interestingly	TTC	is	usually	 triggered	
by	a	physical	or	emotional	 stressor	 in	 the	
patient’s	 life	and	occurs	predominantly	 in	
females,	 though	mortality	 rates	in	males	







































should	 be	provided	 to	 improve	compliance	


































-Ultimately,	 regardless	 of	the	cause	treatment	must	be	provided	 to	avoid	
worsening	 of	LV	dysfunction,	 which	can	lead	to	ventricular	arrhythmias,	
permanent	ventricular	dysfunction	and/or	death.	Since	TTC	 initially	 presents	 in	
a	similar	 fashion	as	ACS,	 the	 treatment	of	the	patient	 should	 follow	 ACS	
guidelines	 initially	 until	 ACS	can	be	 ruled	out	and	TTC	made.	Frequently	 this	
involves	coronary	angiography,	 either	emergently	or	urgently,	 to	rule	out	
obstructive	coronary	artery	disease	 (Scantlebury &	Prasad,	 2014).	
Treatment
-Fortunately,	 conservative	therapy	 that	mimics	general	heart	 failure	
treatment	is	 successful	at	 resolving	most	cases	of	TTC	(Reeder	&	Prasad,	
2015).	Due	to	 the	lack	of	a	unified,	accepted	theory	for	 the	underlying	
pathophysiology	 of	TTC	a	 large	amount	of	treatment	is	 supportive	 in	nature,	




such	as	insertion	 of	an	intra-aortic	balloon	pump	 (IABP),	or	inotropic	 therapy	if	
necessary.	
-Ideally	inotropes	 should	 be	avoided	given	a	 surge	in	catecholamines	 is	
theorized	 to	be	one	of	 the	causative	factors	of	the	disease	 (Reeder	&	Prasad,	
2015).	
-Initially	beta	blockers,	 angiotension-convering enzyme	 inhibitors	 (ACEIs)	or	
angiotensin	 receptor	blockers	 (ARBs)	and	diuretics	 should	 be	used	 to	 treat	LV	
dysfunction	 (Kono &	Sabbah,	2014).	
-Anticoagulation	 should	be	used	 in	 severe	cases	of	LV	failure	 to	prevent	
thromboembolism	 (Reeder	&	Prasad,	2015)	which	could	cause	stroke	or	other	
end-organ	 ischemia.	
-Beta	blockers	have	been	used	 in	 some	patients	 after	recovery	of	LV	
function	due	to	 their	 catecholamine-inhibiting	 nature	however	 there	 is	no	
conclusive	standard	of	care	on	TTC	treatment	(Reeder	&	Prasad,	 2015).
-ACEIs/ARBs,	 diuretics	and	anticoagulation	should	 be	discontinued	 after	LV	




-Profound	shock	treatment	à IABP	&	 inotropic	 therapy	 if	necessary
-Avoidance	of	inotropes	 if	possible	 due	to	 their	possible	 role	 in	 the	disease
-Beta	blockers,	 ACEIs	or	ARBs	 and	diuretics	 for	LV	dysfunction




syndrome	 (ACS)	with	 acute	chest	pain,	dyspnea,	 syncope	and/or	 signs	of	heart	failure	 (Reeder	&	
Prasad,	2015)	with	severe	cases	presenting	 in	cardiogenic	 shock	(Liang,	Cha,	 Oh	&	Prasad,	2013).	
Treatment	for	TTC	is	generally	 supportive,	 with	 the	disease	being	predominantly	benign	 in	nature,	
though	some	individuals	 presenting	with	severe	symptoms	experience	high	mortality	 rates	(Liang,	
Cha,	Oh	&	Prasad,	 2013).	
-The	onset	of	 the	disease	 is	often	caused	by	an	intense	 emotional	 stressor	 such	as	 the	loss	 of	a	
loved	one,	an	interpersonal	 conflict	or	a	catastrophic	medical	diagnosis	 (Sharkey,	Pink,	 Lesser,	
Garberich,	Maron &	Maron,	2015)	but	can	have	physical	 triggers	 such	as	infection,	 surgery	or	
respiratory	 failure,	 while	 some	have	no	obvious	 inciting	events	or	diseases.	 	Women,	 particularly	post-
menopausal	women,	are	at	a	much	greater	risk	 than	males	 for	developing	TTC	with	approximately	
90%	of	cases	occurring	in	 females	(Minhas,	 Hughey &	Kolias,	 2015).
-The	similarity	 in	 symptoms	is	 both	a	blessing	 and	a	curse	as	patients	 who	experience	the	
aforementioned	symptoms	 typically	seek	medical	attention	 relatively	quickly	as	 they	often	associate	
the	symptoms	with	a	heart	attack.	These	same	symptoms	can	easily	be	interpreted	 as	ACS	or	a	STEMI	
by	healthcare	providers,	 as	there	 is	no	unique	sign	or	 symptom	to	distinguish	 between	 the	two	
differential	 diagnoses,	 so	 individuals	 presenting	with	 similar	 symptoms	are	often	 treated	alike	until	
proven	otherwise	 (Scantlebury &	Prasad,	2014).	
Figure	1	Pelliccia,	Greco,	Vitale,	 Rosano,	Gaudio,	 &	Kaski,	 2014
Diagnostic	Tests	&	Features
-Typical	cardiac	diagnostic	 tests	 for	ACS,	STEMI	and	TTC	frequently	 share	similar	 results,	 including	
ST-segment	changes	on	EKG,	elevated	cardiac	biomarkers	and	wall	 motion	abnormalities	 on	
echocardiogram.	
-Emergent	or	urgent	coronary	angiography	 is	 frequently	 required	 to	exclude	the	diagnosis	 of	ACS	or	
STEMI	as	delays	 in	 treatment	for	 these	diagnoses	can	lead	 to	great	 increases	 in	morbidity	and	





1.	Transient	hypokinesis,	 akinesis,	 or	dyskinesis of	 the	left	ventricular	mid-segments	with	or	without	 apical	involvement;	
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